The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 01, 2025

Filed:

Feb. 26, 2020
Applicant:

Memorial Sloan Kettering Cancer Center, New York, NY (US);

Inventors:

Michael R. McDevitt, New York, NY (US);

David A. Scheinberg, New York, NY (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/69 (2017.01); A61K 31/713 (2006.01); A61K 45/06 (2006.01); A61P 13/12 (2006.01); G01N 33/68 (2006.01); C12Q 1/68 (2018.01);
U.S. Cl.
CPC ...
A61K 47/6923 (2017.08); A61K 31/713 (2013.01); A61K 45/06 (2013.01); A61K 47/6929 (2017.08); A61P 13/12 (2018.01); G01N 33/6893 (2013.01); G01N 2333/705 (2013.01); G01N 2800/347 (2013.01); G01N 2800/52 (2013.01);
Abstract

The present disclosure relates generally to methods for treating, preventing, and/or ameliorating chronic kidney disease (CKD) and/or renal injury in a subject in need thereof. In particular, the methods disclosed herein comprise administering a therapeutically effective amount of a pharmaceutical composition comprising at least one Nlrp3 siRNA non-covalently conjugated to sidewall ammonium-functionalized carbon nanotubes (fCNTs), wherein the at least one Nlrp3 siRNA reduces the expression of NLR pyrin domain-containing protein 3 (NLRP3) in a subject diagnosed with, or at risk for CKD and/or renal injury.


Find Patent Forward Citations

Loading…